Growth Metrics

Terns Pharmaceuticals (TERN) Other Working Capital Changes (2020 - 2023)

Terns Pharmaceuticals' Other Working Capital Changes history spans 4 years, with the latest figure at -$2.4 million for Q4 2023.

  • For Q4 2023, Other Working Capital Changes fell 107.63% year-over-year to -$2.4 million; the TTM value through Dec 2023 reached -$666000.0, down 159.41%, while the annual FY2025 figure was $1.2 million, 312.79% up from the prior year.
  • Other Working Capital Changes reached -$2.4 million in Q4 2023 per TERN's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.9 million in Q1 2022 to a low of -$2.4 million in Q4 2023.
  • Average Other Working Capital Changes over 4 years is -$73250.0, with a median of $34500.0 recorded in 2020.
  • The largest YoY upside for Other Working Capital Changes was 1341.38% in 2021 against a maximum downside of 62800.0% in 2021.
  • A 4-year view of Other Working Capital Changes shows it stood at -$1.4 million in 2020, then soared by 54.72% to -$629000.0 in 2021, then tumbled by 87.6% to -$1.2 million in 2022, then tumbled by 107.63% to -$2.4 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Other Working Capital Changes are -$2.4 million (Q4 2023), $1.1 million (Q3 2023), and $574000.0 (Q2 2023).